Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Axcan buying Eurand for $583 million
Yahoo/AP
Wednesday, December 1, 2010 - 11:35am
tags:
Aptalis, M&A
Allergan Lap-Band Effective in Treating More Obese People, FDA Staff Says
Bloomberg
Wednesday, December 1, 2010 - 11:29am
tags:
Allergan, obesity, Lap-Band, FDA
Tylenol plant still plagued by FDA violations
CNN Money
Wednesday, December 1, 2010 - 11:25am
tags:
JNJ, recalls, FDA, Tylenol
Pharmaceutical Company Restructuring Considerations for the Future
Pharmareform
Wednesday, December 1, 2010 - 8:58am
tags:
restructuring
Wyeth Execs Can’t Hide Behind Silence on Antidepressant Data
BNET Pharma
Wednesday, December 1, 2010 - 8:20am
tags:
Wyeth, Pristiq, antidepressants
Teva Announces $1 Billion Share Repurchase Program
Yahoo
Wednesday, December 1, 2010 - 8:11am
tags:
Teva Pharmaceuticals, share repurchase
Simcere Pharmaceutical Group Shares Popped: What You Need to Know
Motley Fool
Wednesday, December 1, 2010 - 8:11am
tags:
China, Simcere
J&J Says $2.3 Billion Crucell Deal May Still Be Renegotiated
Bloomberg
Wednesday, December 1, 2010 - 8:10am
tags:
JNJ, M&A, Crucell, vaccines
Better Buy: Exact Sciences or Sequenom?
Motley Fool
Wednesday, December 1, 2010 - 8:09am
tags:
Sequenom, EXACT Sciences
Bristol-Myers, Otsuka's Schizophrenia Drug Backed for Teens by U.K. Agency
Bloomberg
Wednesday, December 1, 2010 - 8:08am
tags:
Bristol-Myers Squibb, Otsuka, schizophrenia, aripiprazole, UK, Abilify
Novartis will eliminate 1,400 US sales jobs
Yahoo/AP
Wednesday, December 1, 2010 - 7:22am
tags:
Novartis, layoffs, drug reps
Good News for Spectrum Pharma
Yahoo/Zacks.com
Wednesday, December 1, 2010 - 7:21am
tags:
Spectrum Pharmaceuticals, Fusilev, Pfizer, Sanofi, colorectal cancer
Pfizer awards $2M to cancer network
Bizjournals.com
Wednesday, December 1, 2010 - 7:19am
tags:
Pfizer, cancer, philanthropy
Incoming Merck chief to focus on pricing
FT.com
Wednesday, December 1, 2010 - 7:18am
tags:
Merck, Pharma CEOs, pricing, Kenneth Frazier
FDA disputes prostate drugs' risk-cutting power
Fierce Pharma
Tuesday, November 30, 2010 - 10:59am
tags:
FDA, GSK, prostate cancer, Avodart, Merck, Proscar
Drug groups face new generics threat
FT.com
Tuesday, November 30, 2010 - 10:57am
tags:
generics, Roche, Merck, JNJ, Abbott Laboratories, biogenerics
Is a Revenue Miss Coming for Eli Lilly?
Motley Fool
Tuesday, November 30, 2010 - 10:54am
tags:
Eli Lilly
Aegerion Pharma 3Q loss widens on higher costs
Yahoo/AP
Tuesday, November 30, 2010 - 10:53am
tags:
earnings, Aegerion
RNAi Is On Sale
Motley Fool
Tuesday, November 30, 2010 - 10:52am
tags:
RNAi, Merck, Alnylam, Pfizer, Amgen, Novartis, Eli Lilly, Roche
Biotech Calendar: Key Dates for December
TheStreet.com
Tuesday, November 30, 2010 - 9:20am
tags:
Delcath, Arena Pharmaceuticals, RXi Pharmaceuticals, Cell Therapeutics, Amgen, Incyte, Celgene, Corcept Therapeutics, Affymax, Targacept, Exelixis, Orexigen, ONYX Pharmaceuticals, Seattle Genetics, MannKind, Alimera, AstraZeneca, Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.